Induction Therapy of PTX+BV Followed by Atezolizumab+Nab-PTX for PD-L1+ TNBC
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
JAK1 Inhibitor Ivarmacitinib Reversing Immunotherapy Resistance in TNBC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
The Efficacy and Safety of Different Combination Regimens of Inetetamab in First-line Treatment of HER2 Positive Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE4
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Observational Retrospective Study to Assess the Use of Ribociclib in Patients With HR+, HER2- Metastatic Breast Cancer Treated With Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
CARE Initiative: Real-world Emulation of the PALOMA-2 Trial
- Status
- COMPLETED
- Phase
- N/A
A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC
- Status
- RECRUITING
- Phase
- PHASE2
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns
- Status
- RECRUITING
- Phase
- N/A
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2